Plant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease.
Genetic risk
NAFLD
Plant-based diet
UK Biobank
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
12 09 2023
12 09 2023
Historique:
received:
19
02
2023
accepted:
09
08
2023
medline:
13
9
2023
pubmed:
12
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Diets rich in plant-based foods are associated with lower risks of non-alcoholic fatty liver disease (NAFLD), while the prospective evidence is limited. We aimed to examine longitudinal associations of plant-based diets and genetic susceptibility with NAFLD risk. This longitudinal cohort study included 159,222 participants (58.0 ± 8.0 years old, 55.7% female) free of NAFLD in the UK Biobank. We calculated the overall plant-based diet index (PDI), the healthful plant-based diet index (hPDI), and the unhealthful plant-based diet index (uPDI). New-onset NAFLD was the primary outcome. The weighted polygenic risk score was calculated based on risk variants associated with NAFLD. Hazard ratios (HR) and 95% confidential intervals (CI) were estimated by Cox proportional hazards model. Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) measured liver fat content in a subsample of 20,692 participants (57.5 ± 7.4 years old, 52.6% female) was the secondary outcome. The associations between plant-based diet indices and MRI-PDFF were evaluated using generalized linear models. During a median follow-up of 9.5 years, 1541 new-onset NAFLD cases were documented. Compared to the lowest quintile, multivariable-adjusted hazard ratios (HRs) of NAFLD in the highest quintile were 0.78 (95% confidential intervals [CI], 0.66-0.93, p-trend =0.02), 0.74 (95% CI, 0.62-0.87, p-trend <0.0001), and 1.24 (95% CI, 1.05-1.46, p-trend = 0.02) for overall PDI, hPDI, and uPDI, respectively. For liver fat content, higher overall PDI and hPDI were associated with lower MRI-PDFF, while higher uPDI was associated with higher liver fat content. We observed a significant interaction between hPDI and PRS (p-interaction =0.03), and the NAFLD risk was lowest among participants with the highest hPDI and low genetic risk. Higher intake of plant-based diets especially healthful plant-based diets was associated with lower NAFLD risk and liver fat content regardless of genetic susceptibility, whereas an unhealthful plant-based diet was associated with higher NAFLD risk and intrahepatic steatosis. These results suggest that the quality of plant-based foods should be highlighted when adopting a plant-based diet.
Sections du résumé
BACKGROUND
Diets rich in plant-based foods are associated with lower risks of non-alcoholic fatty liver disease (NAFLD), while the prospective evidence is limited. We aimed to examine longitudinal associations of plant-based diets and genetic susceptibility with NAFLD risk.
METHODS
This longitudinal cohort study included 159,222 participants (58.0 ± 8.0 years old, 55.7% female) free of NAFLD in the UK Biobank. We calculated the overall plant-based diet index (PDI), the healthful plant-based diet index (hPDI), and the unhealthful plant-based diet index (uPDI). New-onset NAFLD was the primary outcome. The weighted polygenic risk score was calculated based on risk variants associated with NAFLD. Hazard ratios (HR) and 95% confidential intervals (CI) were estimated by Cox proportional hazards model. Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) measured liver fat content in a subsample of 20,692 participants (57.5 ± 7.4 years old, 52.6% female) was the secondary outcome. The associations between plant-based diet indices and MRI-PDFF were evaluated using generalized linear models.
RESULTS
During a median follow-up of 9.5 years, 1541 new-onset NAFLD cases were documented. Compared to the lowest quintile, multivariable-adjusted hazard ratios (HRs) of NAFLD in the highest quintile were 0.78 (95% confidential intervals [CI], 0.66-0.93, p-trend =0.02), 0.74 (95% CI, 0.62-0.87, p-trend <0.0001), and 1.24 (95% CI, 1.05-1.46, p-trend = 0.02) for overall PDI, hPDI, and uPDI, respectively. For liver fat content, higher overall PDI and hPDI were associated with lower MRI-PDFF, while higher uPDI was associated with higher liver fat content. We observed a significant interaction between hPDI and PRS (p-interaction =0.03), and the NAFLD risk was lowest among participants with the highest hPDI and low genetic risk.
CONCLUSIONS
Higher intake of plant-based diets especially healthful plant-based diets was associated with lower NAFLD risk and liver fat content regardless of genetic susceptibility, whereas an unhealthful plant-based diet was associated with higher NAFLD risk and intrahepatic steatosis. These results suggest that the quality of plant-based foods should be highlighted when adopting a plant-based diet.
Identifiants
pubmed: 37697334
doi: 10.1186/s12916-023-03028-w
pii: 10.1186/s12916-023-03028-w
pmc: PMC10496397
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
351Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Front Nutr. 2021 Nov 22;8:784354
pubmed: 34881283
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861
pubmed: 35798021
Hepatology. 2019 Oct;70(4):1457-1469
pubmed: 30924946
Hepatology. 2021 Jul;74(1):474-482
pubmed: 33486773
Front Nutr. 2020 Nov 19;7:593735
pubmed: 33330594
Hepatology. 2018 Apr;67(4):1348-1359
pubmed: 29108123
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2524-2532.e2
pubmed: 34752964
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Nutrients. 2022 Jul 12;14(14):
pubmed: 35889803
J Am Coll Cardiol. 2017 Jul 25;70(4):411-422
pubmed: 28728684
Lancet. 2019 Feb 2;393(10170):447-492
pubmed: 30660336
PLoS One. 2017 Feb 27;12(2):e0172921
pubmed: 28241076
Clin Nutr. 2019 Aug;38(4):1672-1677
pubmed: 30578029
Lancet. 2021 Jun 5;397(10290):2212-2224
pubmed: 33894145
PLoS Med. 2016 Jun 14;13(6):e1002039
pubmed: 27299701
Am J Epidemiol. 2019 Oct 1;188(10):1858-1867
pubmed: 31318012
JAMA Intern Med. 2020 Aug 1;180(8):1090-1100
pubmed: 32539102
J Hepatol. 2018 May;68(5):1063-1075
pubmed: 29408694
Public Health Nutr. 2011 Nov;14(11):1998-2005
pubmed: 21729481
Eur J Epidemiol. 2020 Nov;35(11):1069-1085
pubmed: 32323115
Gastroenterology. 2018 Jul;155(1):107-117
pubmed: 29604292
Clin Nutr. 2021 May;40(5):2508-2519
pubmed: 33932796
Crit Rev Food Sci Nutr. 2017 Mar 4;57(4):834-855
pubmed: 25897647
J Hepatol. 2020 Jun;72(6):1196-1209
pubmed: 32145256
Circulation. 2016 Jan 12;133(2):187-225
pubmed: 26746178
J Hepatol. 2022 May;76(5):1021-1029
pubmed: 35085594
Nutrients. 2022 Oct 02;14(19):
pubmed: 36235752
Front Nutr. 2021 Sep 17;8:642509
pubmed: 34604270
Am J Gastroenterol. 2021 Aug 1;116(8):1667-1675
pubmed: 33767101
Curr Opin Lipidol. 2002 Feb;13(1):3-9
pubmed: 11790957
J Hepatol. 2020 Aug;73(2):241-251
pubmed: 32247823
Int J Food Sci Nutr. 2022 Sep;73(6):809-820
pubmed: 35403524
Lancet. 2022 Jul 16;400(10347):185-235
pubmed: 35843246
Nat Rev Endocrinol. 2022 Jan;18(1):55-66
pubmed: 34815553
Hepatology. 2020 Jun;71(6):1940-1952
pubmed: 31553803
Gastroenterology. 2017 Feb;152(3):571-585.e8
pubmed: 27765690
Am J Clin Nutr. 2022 Oct 6;116(4):1078-1090
pubmed: 35731596
Liver Int. 2019 Sep;39(9):1732-1741
pubmed: 31162803
Am J Clin Nutr. 2020 Aug 1;112(2):354-363
pubmed: 32453423
Gastroenterology. 2016 Jun;150(8):1728-1744.e7
pubmed: 26873399
Crit Rev Food Sci Nutr. 2023;63(20):4675-4686
pubmed: 34871105
Liver Int. 2017 Jul;37(7):936-949
pubmed: 28371239